将患者观点纳入指南制定:指导文件的系统综述
该系统综述评估了用于制定临床指南的指导文件如何处理患者观点的纳入。检索2017年五个数据库,纳入56个机构的指导文件。其中40个(71.4%)建议纳入患者或代表,但仅47.5%(19/40)提供了具体方法。结论认为多数机构建议纳入患者观点,但细节不足,机构应提供更多指导。
要点
- 56个机构的指导文件中,40个(71.4%)建议纳入患者或代表。
- 仅47.5%(19/40)的机构提供了纳入患者的具体方法。
- 75.0%(30/40)的机构建议了获取患者观点的来源。
核心结论
- 多数机构建议在制定临床指南时纳入患者及其观点,但关于如何操作的具体细节很少。
- 机构应提供更多指导,因为这可能对指南的适用性产生积极影响。
研究设计与样本
- 系统综述,检索2017年五个数据库,由两名作者筛选研究并双人核对数据提取。
- 纳入56个机构的指导文件,评估其关于纳入患者或代表以及患者观点的方法学内容。
主要发现
- 40个(71.4%)机构建议纳入患者或代表,主要用于制定推荐(14/40,35.0%)、审查最终版本(13/40,32.5%)、形成临床问题(13/40,32.5%)、定义范围和目标(10/40,25.0%)以及传播与实施(10/40,25.0%)。
- 47.5%(19/40)的机构提供了关于如何纳入患者的具体方法。
- 40个(71.4%)机构提供了纳入患者观点的额外策略;其中30个(75.0%)建议了获取这些观点的来源:与患者咨询(24/40,60.0%)、使用小组判断(10/40,25.0%)、开展新研究(10/40,25.0%)或系统综述(9/40,22.5%)。
关键数值与推荐
- 40个(71.4%)机构建议纳入患者或代表。
- 47.5%(19/40)的机构提供了纳入患者的具体方法。
- 30个(75.0%)机构建议了获取患者观点的来源,包括与患者咨询(24/40,60.0%)、使用小组判断(10/40,25.0%)、开展新研究(10/40,25.0%)或系统综述(9/40,22.5%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess how guidance documents for developing clinical guidelines (CGs) address the incorporation of patients' views in CGs. STUDY DESIGN AND SETTING: Systematic review to identify the methodology provided in guidance documents for incorporating (1) patients or representatives and (2) patients' views in the CG development process. The search was performed in 2017 in five databases. Two authors selected the studies, and data extraction was double-checked. RESULTS: We included guidance documents from 56 institutions. Of those, 40 (71.4%) recommended the inclusion of patients or their representatives, mainly for developing recommendations (14/40, 35.0%); reviewing the final version (13/40, 32.5%); formulating clinical questions (13/40, 32.5%); defining the scope and objectives (10/40, 25.0%); and dissemination and implementation (10/40, 25.0%). Concrete methods on how to incorporate patients were provided by 47.5% (19/40) of institutions. Forty (71.4%) institutions provided additional strategies to incorporate patients' views. The majority (30/40, 75.0%) suggested sources for obtaining these views (consultation with patients [24/40, 60.0%], using panels' judgment [10/40, 25.0%], conducting de novo research [10/40, 25.0%], or a systematic review [9/40, 22.5%]). CONCLUSION: Although most institutions suggest incorporating patients and their views when developing CGs, little detail is provided on how to do this. Institutions should provide more guidance as this could have a positive impact in guideline applicability.
引用
- Selva A, Sanabria AJ, Pequeño S, et al. Incorporating patients' views in guideline development: a systematic review of guidance documents. J Clin Epidemiol. 2017. PMID: 28579379. doi:10.1016/j.jclinepi.2017.05.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。